-+ 0.00%
-+ 0.00%
-+ 0.00%

Poinsettia (300723.SZ): Two products plan to win the bid for the 12th batch of centralized procurement of national drugs

Zhitongcaijing·08/03/2026 03:57:04
Listen to the news

Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. On July 31, 2026, the company's wholly-owned subsidiary Guangzhou Yipinhong Pharmaceutical Co., Ltd. (hereinafter referred to as “Yipinhong Pharmaceutical”) and Guangzhou Lianrui Pharmaceutical Co., Ltd. (hereinafter referred to as “Lianrui Pharmaceutical”) participated in the bidding process for the 12th batch of centralized national drug procurement organized by the State Organization Drug Joint Procurement Office. Yipinhong Pharmaceutical used injectable isaconazole sulfate and Lianrui Pharmaceuticals to pass the consistent evaluation of generic drug quality and efficacy. Ammonia chloride Horizon Film (III) plans to win the bid for this centralized procurement.

The company plans to win the bid for injectable isaconazole sulfate to achieve sales revenue of 0.0,000 yuan in 2025; perindopril amlodipine tablets (III) achieved sales revenue of 3.481,700 yuan in 2025, accounting for 0.37% of the company's revenue in 2025.